Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Alivus Life Sciences Ltd.
NSE: ALIVUS
|
BSE: 543322
|
ISIN: INE03Q201024
|
Industry: Pharmaceuticals
|
Slowing Down Stock
944.1000
-14.30
(
-1.49
%)
NSE
Aug 14, 2025
15:31 PM
29.29% Fall from 52W High
Volume:
60,684
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Alivus Life Sciences Ltd.
18 Mar 2025
944.10
-1.49%
BP Equities Alivus lifesciences Initiating Coverage BUY Target 1,317
Buy:
Alivus Life Sciences Ltd.
by
BP Wealth
Target: 1317 | Upside : 39.5%
BP Wealth
Alivus Life Sciences Ltd. is trading below all available SMAs
More from Alivus Life Sciences Ltd.
All Rapid Results
Recommended
Five Interesting Stocks Today - August 14, 2025
The Baseline |
14 Aug 2025, 04:39PM
Market closes flat, Amara Raja's Q1 net profit drops 20.7% YoY to Rs 194 crore
Trendlyne Marketwatch |
14 Aug 2025, 03:56PM
Glenmark Life Sciences: The hived off API business of Glenmark Pharma goes public
|
27 Jul 2021